Parkinson's Congress 2026: Deciphering the kinetic code

The German Congress for Parkinson's and Movement Disorders 2026, themed "From Gene to System – The Kinetic Code," focuses on the systemic control of movement. DPA Med builds on this theme with a non-invasive, robot-assisted therapy approach that aims to utilize rhythmic stimuli for movement organization.

The professional discussion surrounding Parkinson's disease is shifting: in addition to dopaminergic mechanisms, disorders of movement organization, timing, and sensorimotor coupling are coming into focus. At the 2026 congress in Leipzig, abavital GmbH is positioning DPA Med precisely at this juncture: as a method that improves gait patterns, pelvic mobility, and motor accessibility through structured, body-based stimulation. It supports treatment teams in preparing active therapies.

The Parkinson's Congress 2026: Movement as a system performance

The congress motto, "From Gene to System – The Kinetic Code," marks a shift in perspective. Parkinson's disease is no longer described solely as a biochemical deficit, but rather as a disorder of complex motor control at the systemic level. The congress organizers emphasize the path from molecular biological foundations to systemic therapy. For the first time, the German Physical Society (DPG), the Botulinum Toxin Working Group, and the Deep Brain Stimulation Working Group are jointly organizing the program. Keynote speeches on network stimulation and the glymphatic system make it clear that the treatment of movement disorders is being conceived more broadly and interdisciplinarily than ever before.

When the starting signal fails – and training alone is not enough

Hesitancy to start, disturbed gait rhythm, freezing: In Parkinson's disease, the problem often lies not in a lack of strength, but in the temporal organization of movements. DPA Med builds on this insight. When the internal clock cannot be reliably accessed, structured external rhythmic stimuli gain therapeutic importance – not as a replacement for drug treatment or invasive procedures, but as a targeted approach to motor organization at the system level.

The technique: Lemniscate, oscillation, and targeted afferent stimulation for gait patterns and pelvis.

DPA Med utilizes a three-dimensional, lemniscate-shaped movement pattern that generates continuously changing acceleration vectors, alternating weight shifts, and rotational micro-impulses. Controlled unloading and multi-stage oscillations are used to deliver targeted proprioceptive stimuli. These stimuli play a central role in sensorimotor organization and support fundamental functions such as:

The result is a structured afferent stimulus pattern that specifically targets sensorimotor coupling. The system operates robotically and reproducibly, which can also contribute to relieving the workload of therapeutic teams in clinical practice.

DPA Med addresses a key weakness in Parkinson's therapy

DPA Med focuses on the impaired temporal organization of movement as the central theme of treatment. Developed in France, the system has been used in therapy centers there for approximately ten years and is designed for use in multimodal therapy concepts. The goal is to create the conditions that allow gait training, functional physiotherapy, and neurocognitive rehabilitation to begin in a more favorable motor state. DPA Med thus occupies a clear therapeutic role: as a specific approach to a movement problem that is not always adequately addressed by conventional approaches alone.

On-site demonstration and expert discussion

During the congress, DPA Med plans demonstrations and expert discussions. The focus will be on integrating the system into neurological and rehabilitative care pathways. The target audience includes physicians, physiotherapists, and specialist media involved in the further development of multimodal Parkinson's therapy.

Fact box

About DPA Med / abaVital GmbH

abaVital GmbH in Leipzig develops and distributes DPA Med – a robot-assisted mobilization and stimulation system for neurological and rehabilitative applications. The system utilizes a patented, three-dimensional lemniscate movement and defined oscillation levels. It is designed for professionals seeking a reproducible, body-based approach to motor therapy within multimodal treatment concepts.